Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Corvus Pharmaceuticals, Inc.

CRVS Technical Analysis Summary (NASDAQ)

Analyze CRVS on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

CRVS●NASDAQ
HealthcareBiotechnology
$12.92
$0.15(1.15%)
U.S. Market opens in 14h 24m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

CRVS Technical Analysis Summary (NASDAQ)

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 40.37)
Trend Strength:Weak (ADX: 19.36)
Volatility:High (ATR: 0.79)
Support/Resistance:$13.02 – $16.41 (Bollinger Bands)

Technical conditions suggest Corvus Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Corvus Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 40.37

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 2.86

Bullish
Oversold zone signals rebound potential.

Williams %R: -99.00

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -16.70

Strongly Bearish
Sharp downside momentum.

Takeaway:Corvus Pharmaceuticals, Inc. shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: 0.00

Neutral
Neutral, momentum shows no clear direction.

ADX: 19.36

Weak
Weak trend, market trading sideways.

ATR (14): 0.79

Low
Low volatility, stable price action.

CCI (14): -139.09

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Corvus Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$16.41
Middle Band (SMA 20)
$14.71
Lower Band
$13.02
Current Position
Below Lower Band

Takeaway:Corvus Pharmaceuticals, Inc. trades near the lower band, signaling oversold conditions and potential rebound.

Keltner Channels
Upper Channel
$15.66
Middle Line (EMA 20)
$14.08
Lower Channel
$12.51
Squeeze Status
No Squeeze

Takeaway:Corvus Pharmaceuticals, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-11.58M
Money Flow Index37.39Bearish, selling pressure outweighs inflows.
Relative Vigor Index33.39Bearish, price momentum favors sellers.

Overall Takeaway:CRVS shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Corvus Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: CRVS) Technical Analysis FAQ